MILETIC, Sean; HUENERBERG, Martin; KALDIS, Angelo; MACDONALD, Jacqueline; LEUTHREAU, Antoine; MCALLISTER, Tim; MENASSA, Rima

doi:10.1002/biot.201700405

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

MILETIC, Sean
Department of Biology
Agriculture and Agri-Food [AAFC]

HUENERBERG, Martin
Lethbridge Research Development Centre
Georg-August-University = Georg-August-Universität Göttingen

KALDIS, Angelo
Agriculture and Agri-Food [AAFC]

Langue

Article de revue

Ce document a été publié dans

Biotechnology Journal. 2017, vol. 12, n° 10

Wiley-VCH Verlag

Résumé en anglais

Enterohemorrhagic Escherichia coli (EHEC) are commonly present in the gastrointestinal tract of cattle and cause serious infectious disease in humans. Immunizing cattle against EHEC is a promising strategy to decrease the risk of food contamination; however, veterinary vaccines against EHEC such as Econiche have not been widely adopted by the agricultural industry, and have been discontinued, prompting the need for more cost-effective EHEC vaccines. The objective of this project is to develop a platform to produce plant-made antigens for oral vaccination of ruminants against EHEC. Five recombinant proteins were designed as vaccine candidates and expressed transiently in Nicotiana benthamiana and transplastomically in Nicotiana tabacum. Three of these EHEC proteins, NleA, Stx2b, and a fusion of EspA accumulated when transiently expressed. Transient protein accumulation was the highest when EHEC proteins were fused to an elastin-like polypeptide (ELP) tag. In the transplastomic lines, EspA accumulated up to 479mgkg(-1) in lyophilized leaf material. Sheep that were administered leaf tissue containing recombinant EspA shed less E. coli O157:H7 when challenged, as compared to control animals. These results suggest that plant-made, transgenic EspA has the potential to reduce EHEC shedding in ruminants.< Réduire

Mots clés

EHEC

Mots clés en anglais

E. coli O157:H7

molecular farming

oral vaccine

veterinary vaccines